Portfolio (Quarterly)
Guide ↗
ADAR1 Capital Management, LLC
· CIK 0001940272| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 281 | — | NEUPHORIA THERAPEUTICS INC | — | 30,000.0 | $122K | 0.01% | NEW | — | $4.07 | — |
| 282 | MIST | MILESTONE PHARMACEUTICALS IN | Healthcare | 100,000.0 | $119K | 0.01% | NEW | — | $1.19 | +27.7% |
| 283 | ARCT | ARCTURUS THERAPEUTICS HLDGS | Healthcare | 15,000.0 | $116K | 0.01% | NEW | — | $7.72 | -9.1% |
| 284 | MGNX | MACROGENICS INC | Healthcare | 40,000.0 | $116K | 0.01% | NEW | — | $2.89 | +46.7% |
| 285 | CCCC | C4 THERAPEUTICS INC | Healthcare | 43,000.0 | $113K | 0.01% | NEW | — | $2.63 | +33.8% |
| 286 | RXRX | RECURSION PHARMACEUTICALS IN | Healthcare | 35,000.0 | $107K | 0.01% | NEW | — | $3.07 | -3.6% |
| 287 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 10,000.0 | $106K | 0.01% | NEW | — | $10.64 | +3.5% |
| 288 | GOSS | GOSSAMER BIO INC | Healthcare | 287,531.0 | $94K | 0.01% | NEW | — | $0.33 | -38.8% |
| 289 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 10,000.0 | $91K | 0.01% | NEW | — | $9.11 | -4.8% |
| 290 | STI CALL | SOLIDION TECHNOLOGY INC | Industrials | 13,500.0 | $85K | 0.01% | NEW | — | $6.31 | -25.2% |
| 291 | LITS | LITE STRATEGY INC | Healthcare | 67,292.0 | $78K | 0.01% | NEW | — | $1.16 | -5.2% |
| 292 | VERU | VERU INC | Healthcare | 35,000.0 | $77K | 0.01% | NEW | — | $2.21 | -1.8% |
| 293 | KYNB | KYNTRA BIO INC | Healthcare | 10,469.0 | $71K | 0.00% | NEW | — | $6.78 | +2.4% |
| 294 | CLOV | CLOVER HEALTH INVESTMENTS CO | Healthcare | 40,000.0 | $70K | 0.00% | NEW | — | $1.76 | +104.5% |
| 295 | BMEA | BIOMEA FUSION INC | Healthcare | 43,420.0 | $66K | 0.00% | NEW | — | $1.53 | -10.5% |
| 296 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 33,100.0 | $65K | 0.00% | NEW | — | $1.95 | -5.1% |
| 297 | OGN | ORGANON & CO | Healthcare | 10,000.0 | $60K | 0.00% | NEW | — | $5.99 | +124.0% |
| 298 | ESPR | ESPERION THERAPEUTICS INC NE | Healthcare | 21,400.0 | $59K | 0.00% | NEW | — | $2.74 | +14.2% |
| 299 | MREO | MEREO BIOPHARMA GROUP PLC | Healthcare | 150,000.0 | $50K | 0.00% | NEW | — | $0.33 | -17.5% |
| 300 | ANTX | AN2 THERAPEUTICS INC | Healthcare | 13,861.0 | $47K | 0.00% | NEW | — | $3.42 | +43.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
94.6%
Financial Services
4.9%
Real Estate
0.1%
Consumer Cyclical
0.1%
Technology
0.1%
Communication Services
0.1%
Industrials
0.1%
Basic Materials
0.1%